MeVis Medical Solutions AGFRA:M3V 66 Gross Margin % is 98.04% as of Mar. 2026, which is 1% above its 10-year median of 97.19. GuruFocus rates FRA:M3V with a GF Score™ of 66/100 and a GF Value™ of €22.52. The stock has 4 warning signs investors should review. Among 629 Healthcare Providers & Services companies, MeVis Medical Solutions AG ranks better than 98.73% on this metric.
FRA:M3V's Gross Margin % is ranked better than 98.73% of 629
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs FRA:M3V: 97.84
MeVis Medical Solutions AG had a gross margin of 98.04% for the quarter that ended in Mar. 2026 => Durable competitive advantage
MeVis Medical Solutions AG (FRA:M3V) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
MeVis Medical Solutions AG had a gross margin of 98.04% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
MeVis Medical Solutions AG Gross Margin % Related Terms
MeVis Medical Solutions AG Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:M3V vs VEEV, BTSG, TEM: Gross Margin % Comparison
For the Health Information Services subindustry, MeVis Medical Solutions AG's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeVis Medical Solutions AG Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's Gross Margin % distribution charts can be found below:
* The bar in red indicates where MeVis Medical Solutions AG's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
MeVis Medical Solutions AG (FRA:M3V) has a Gross Margin % of 98.04% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on MeVis Medical Solutions AG and its competitors. This is near median its historical median of 97.19. Over the past decade, MeVis Medical Solutions AG's Gross Margin % has ranged from 96.02 to 97.84. According to the industry distribution chart, MeVis Medical Solutions AG ranks #8 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 1.3%.
Is MeVis Medical Solutions AG's Gross Margin % too high?
MeVis Medical Solutions AG's current Gross Margin % of 98.04% is near median its 10-year median of 97.19. Over the past 10 years, this metric has ranged from a low of 96.02 to a high of 97.84. The Healthcare Providers & Services industry median Gross Margin % is 40.09. MeVis Medical Solutions AG's value of 98.04% is 144.5% above this industry median. Based on the distribution chart, MeVis Medical Solutions AG ranks #8 out of 629 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MeVis Medical Solutions AG has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's Gross Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MeVis Medical Solutions AG ranks #8 out of 629 companies for Gross Margin %. This places MeVis Medical Solutions AG in the top 1% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.09. MeVis Medical Solutions AG's value of 98.04% is 144.5% above this benchmark. Historically, MeVis Medical Solutions AG's own Gross Margin % has ranged from 96.02 to 97.84 over the past decade. While the company's 10-year median is 97.19 vs. the industry median of 40.09, MeVis Medical Solutions AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MeVis Medical Solutions AG's current Gross Margin % of 98.04% is 144.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on MeVis Medical Solutions AG and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MeVis Medical Solutions AG's current Gross Margin % is 98.04%, which is near median its own 10-year median of 97.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
MeVis Medical Solutions AG (FRA:M3V) has a current Gross Margin % of 98.04%. The stock's GF Value™ is €22.52, compared to a current price of €23.20 — trading 3% above its estimated fair value. The current Gross Margin % is 98.04%, which is near median its 10-year median of 97.19 and 144.5% above the Healthcare Providers & Services industry median of 40.09. MeVis Medical Solutions AG's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current Gross Margin % is 98.04% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?
Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued.
The current stock price of €23.20 is trading 3% above its estimated GF Value™ of €22.52.
Key valuation signals for FRA:M3V:
Gross Margin %: 98.04% (near median its 10-year median of 97.19)
GF Value™: €22.52 vs. price of €23.20 (3% above fair value)
Industry Position: 144.5% above the Healthcare Providers & Services median (#8 of 629)
No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score
Get the complete analysis for FRA:M3V
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3V has been successfully added to your 
